Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00892866 · ClinicalTrials.gov registry record · NA
CA-IX, p16, Proliferative Markers, and HPV in Diagnosing Cervical Lesions in Patients With Abnormal Cervical Cells
A NA study of Human Papillomavirus Infection and Atypical Endometrial Hyperplasia, sponsored by GOG Foundation.
- Active
- Registry status
- NA
- Development phase
- 877
- Enrollment target
- 20
- Study locations
NCT00892866 is a NA study of Human Papillomavirus Infection and Atypical Endometrial Hyperplasia that is active but no longer recruiting, run by GOG Foundation. The registered enrollment target is 877 participants, below the 1,267-participant average among 17 other Human Papillomavirus Infection trials with a reported enrollment target (31% lower). The trial reports 20 study locations across 5 states.
The verdict
NCT00892866, a NA study of Human Papillomavirus Infection and Atypical Endometrial Hyperplasia, is active but no longer recruiting, sponsored by GOG Foundation.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 877 participants
- Enrollment target
- 20
- Study locations
Study Summary
This research trial studies carbonic anhydrase 9 (CA-IX), p16, proliferative markers, and human papilloma virus (HPV) in diagnosing cervical lesions in patients with abnormal cervical cells. Studying biomarkers in abnormal cervical cells may improve the ability to find cervical lesions and plan effective treatment.
Conditions Studied
Interventions
- OTHER Laboratory Biomarker Analysis
- OTHER Cytology Specimen Collection Procedure
Study Locations (20)
Idaho
- Saint Alphonsus Cancer Care Center-Boise - Boise
- Saint Alphonsus Cancer Care Center-Caldwell - Caldwell
- Kootenai Health - Coeur d'Alene - Coeur d'Alene
- Walter Knox Memorial Hospital - Emmett
- Idaho Urologic Institute-Meridian - Meridian
- Saint Alphonsus Medical Center-Nampa - Nampa
- Kootenai Clinic Cancer Services - Post Falls - Post Falls
- Kootenai Cancer Clinic - Sandpoint
California
- UC San Diego Moores Cancer Center - La Jolla
- Kaiser Permanente Los Angeles Medical Center - Los Angeles
- UCLA / Jonsson Comprehensive Cancer Center - Los Angeles
- Saint Joseph Hospital - Orange - Orange
- UC Irvine Health/Chao Family Comprehensive Cancer Center - Orange
- Olive View-University of California Los Angeles Medical Center - Sylmar
Arizona
- Banner University Medical Center - Tucson - Tucson
- University of Arizona Cancer Center-North Campus - Tucson
Connecticut
- Hartford Hospital - Hartford
- The Hospital of Central Connecticut - New Britain
Illinois
- NorthShore University HealthSystem-Evanston Hospital - Evanston
- Good Samaritan Regional Health Center - Mount Vernon
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 877 participants |
| Start Date | 2009-04-13 |
| Est. Completion | 2025-05-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00892866
The ClinicalTrials.gov registry entry for NCT00892866 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 877 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,267-participant average among 17 other Human Papillomavirus Infection trials with a reported enrollment target (31% lower). The listed sponsor is GOG Foundation, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Human Papillomavirus Infection appearing as the primary indexed condition, and to 2 interventions - of which Laboratory Biomarker Analysis is the first listed.
NCT00892866 reports 20 study locations spanning 5 distinct geographic areas - top geographies include Idaho, California, Arizona.
Frequently Asked Questions
What is clinical trial NCT00892866 about?
NCT00892866 is a clinical study titled "CA-IX, p16, Proliferative Markers, and HPV in Diagnosing Cervical Lesions in Patients With Abnormal Cervical Cells". This research trial studies carbonic anhydrase 9 (CA-IX), p16, proliferative markers, and human papilloma virus (HPV) in diagnosing cervical lesions in patients with abnormal cervical cells. Studying biomarkers in abnormal cervical cells may improve the ability to find cervical lesions and plan effe...
What is the current status of trial NCT00892866?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 877 participants. The study started on 2009-04-13. Estimated completion is 2025-05-31.
What conditions does trial NCT00892866 study?
This clinical trial studies the following conditions: Human Papillomavirus Infection, Atypical Endometrial Hyperplasia, Stage 0 Cervical Cancer AJCC v7.
What interventions are being tested in trial NCT00892866?
The interventions under investigation include: Laboratory Biomarker Analysis (OTHER), Cytology Specimen Collection Procedure (OTHER).
Who is sponsoring clinical trial NCT00892866?
This trial is sponsored by GOG Foundation, which has 14 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00892866 being conducted?
This trial has 20 study locations across Arizona, California, Connecticut, Idaho, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Human Papillomavirus Infection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Investigating Facilitator-driven, Multi-level Implementation Strategies in Federally Qualified Health Centers to Improve Provider Recommendation and HPV Vaccination Rates Among Latino/a Adolescents
RECRUITING · NA
-
Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S04)
RECRUITING · NA
-
Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S01)
RECRUITING · NA
-
Feasibility Trial of a Multi-level Media Production and Social Marketing Campaign to Reduce HPV Vaccine Hesitancy
RECRUITING · NA
-
Anal Cytology Collection Procedures in Predicting High-Grade Anal Dysplasia in Men Who Have Sex With Men
ACTIVE NOT RECRUITING · NA
-
Prospective Evaluation of Self-Testing to Increase Screening (PRESTIS) Asian/Asian American Women Supplement
ACTIVE NOT RECRUITING · NA
Explore more on PlainTrial
Human Papillomavirus Infection
All registered trials for this condition
Atypical Endometrial Hyperplasia
All registered trials for this condition
Arizona
All trials with a study site in Arizona
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.